Literature DB >> 17997274

A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization.

Gowrisankar Rajam1, Donald J Phillips, Elizabeth White, Julie Anderton, Craig W Hooper, Jacquelyn S Sampson, George M Carlone, Edwin W Ades, Sandra Romero-Steiner.   

Abstract

Pneumococcal surface adhesin A (PsaA) is a putative pneumococcal (Pnc) adhesin known to bind to nasopharyngeal (NP) epithelial cells. This study evaluated the effect of peptides within a functional domain of PsaA on NP cells. Detroit 562 NP cells were treated with synthetic peptides derived from PsaA (P4, P6, and P7; 28, 12, and 16 amino acids, respectively). The P4 peptide also binds to NP cells. Analysis of P4-treated NP cells by transmission electron microscopy revealed major cytological changes. Of 9 cytokines analyzed, a 6-fold increase in FGFb secretion at 3 and 6h (11-fold at 12h) was found post-P4 treatment of NP cells. There was a simultaneous reduction in the secreted levels of IL-6, IL-8, and VEGF. We observed enhancement in the adherence of Pnc strains to P4-treated NP cells (2-38-fold increase). Enhancement in adherence (2-fold increase) to P4-treated NP cells was also recorded with other streptococcal species (Streptococcus mitis and Streptococcus pyogenes). Internalization experiments demonstrated that 45% of the adherent bacteria were actually internalized after pretreatment with P4 peptide as compared to controls. Peptide fragments of P4, P6 and P7 did not activate NP cells to the extent of P4 peptide. The P4-mediated enhancement of Pnc adherence was blocked (100%) by anti-P4 antibodies, confirming the specificity of the P4 sequence for NP cell activation. Our data suggests that this functional domain of PsaA contained within the P4 sequence binds and activates NP cells to facilitate Pnc invasion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17997274     DOI: 10.1016/j.micpath.2007.09.003

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  13 in total

1.  P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.

Authors:  Gowrisankar Rajam; Mathieu Bangert; Gabrielle M Hammons; Nikkol Melnick; George M Carlone; Jacquelyn S Sampson; Edwin W Ades
Journal:  Clin Vaccine Immunol       Date:  2010-09-15

2.  The Pneumococcal Serotype 15C Capsule Is Partially O-Acetylated and Allows for Limited Evasion of 23-Valent Pneumococcal Polysaccharide Vaccine-Elicited Anti-Serotype 15B Antibodies.

Authors:  Brady L Spencer; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2017-08-04

3.  Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.

Authors:  Shifeng Wang; Yuhua Li; Huoying Shi; Giorgio Scarpellini; Ascencion Torres-Escobar; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

4.  Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

Authors:  Jenni N Weeks; Kelli L Boyd; Gowrisankar Rajam; Edwin W Ades; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

5.  Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.

Authors:  Masahide Yano; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2010-11-10

6.  Varied metal-binding properties of lipoprotein PsaA in Streptococcus pneumoniae.

Authors:  Nan Li; Xiao-Yan Yang; Zhong Guo; Jing Zhang; Kun Cao; Junlong Han; Gong Zhang; Langxia Liu; Xuesong Sun; Qing-Yu He
Journal:  J Biol Inorg Chem       Date:  2014-02-20       Impact factor: 3.358

7.  Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.

Authors:  Nikkol Melnick; Gowrisankar Rajam; George M Carlone; Jacquelyn S Sampson; Edwin W Ades
Journal:  Clin Vaccine Immunol       Date:  2009-04-22

8.  NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae.

Authors:  Xinjie Liu; Vinita S Chauhan; Amy B Young; Ian Marriott
Journal:  Glia       Date:  2010-05       Impact factor: 7.452

9.  A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia.

Authors:  Gowrisankar Rajam; Gabrielle M Hammons; George M Carlone; Jacquelyn S Sampson; Edwin W Ades
Journal:  Int J Microbiol       Date:  2011-11-16

10.  Phenotypic, genomic, and transcriptional characterization of Streptococcus pneumoniae interacting with human pharyngeal cells.

Authors:  Sheila Z Kimaro Mlacha; Sandra Romero-Steiner; Julie C Dunning Hotopp; Nikhil Kumar; Nadeeza Ishmael; David R Riley; Umar Farooq; Todd H Creasy; Luke J Tallon; Xinyue Liu; Cynthia S Goldsmith; Jacquelyn Sampson; George M Carlone; Susan K Hollingshead; J Anthony G Scott; Hervé Tettelin
Journal:  BMC Genomics       Date:  2013-06-09       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.